Effect of metabolic acidosis on the insulin-like growth factor-I system and cathepsins B and L gene expression in the kidney

Journal of Laboratory and Clinical Medicine

Volumn 136, Issue 6, 2000, Pages 468-475

  Fawcett, Janet ^a,b   Hsu, Fay W ^a   Tsao, Tanny ^a   Rabkin, Ralph ^a  

^a STANFORD UNIVERSITY   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033667750     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.110606     Document Type: Article

References (29)

1. Effect of metabolic acidosis on the expression of insulin-like growth factor and growth hormone receptor
2. Metabolic acidosis inhibits growth hormone secretion in rats: Mechanism of growth retardation
3. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans
4. Nutritional regulation of the insulin-like growth factors
5. Kidney IGF-I accumulation occurs in four different conditions with rapid initial kidney growth in rats
6. The IGF-I axis in kidney and skeletal muscle of potassium deficient rats
7. Regulation of the insulin-like growth factor system by acute acidosis
8. Renal adaptation during chronic NH4Cl acidosis in the rat: No role for hyperplasia
9. Growth hormone, the insulin-like growth factor system, and the kidney
10. Renal tubular cell protein breakdown in uninephrectomized and ammonium chloride-loaded rats
11. Renal hypertrophy in metabolic acidosis and its relationship to ammonia excretion
12. Some metabolic effects of ammonia on astrocytes and neurons in primary cultures
13. Induction of hypertrophy in cultured proximal tubule cells by extracellular NH4Cl
14. Mesangial cell hypertrophy induced by NH4Cl: Role of depressed activities of cathepsins due to elevated lysosomal pH
15. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway
16. Renal growth hormone-insulin-like growth factor-I system in acute renal failure
17. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6)
18. Mouse serum growth hormone (GH) binding protein has GH receptor extracellular and substituted transmembrane domains
19. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors
20. Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels
21. Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: Evidence for differential processing and regulation in liver
22. The human 18S ribosomal RNA gene: Evolution and stability
23. Analysis of serum insulin-like growth factor binding proteins using western blotting: Use of the method for titration of the binding proteins and competitive binding studies
24. Distribution of circulating insulin-like growth factor-I (IGF-I) into tissues
25. Failure of insulin-like growth factor-I (IGF-I) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations
26. Expression of the insulin-like growth factor system in the hypokalemic rat kidney
27. Expression of insulin-like growth factor-1 and transforming growth factor-β in hypokalemic nephropathy in the rat
28. Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling
29. The lysosomal proton pump and its effect on protein breakdown